Skip to main content

Investigation into Cu-64-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents

McQuade, Paul, Martin, Kath E., Castle, Thomas C., Went, Michael J., Blower, Philip J., Welch, Michael J., Lewis, Jason S. (2005) Investigation into Cu-64-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents. Nuclear Medicine and Biology, 32 (2). pp. 147-156. ISSN 0883-2897. (doi:10.1016/j.nucmedbio.2004.10.004) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:3764)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.
Official URL:
http://dx.doi.org/10.1016/j.nucmedbio.2004.10.004

Abstract

Background: Cu-diacetyl-bis(N-4-methylthiosemicarbazone)[Cu-ATSM], although excellent for oncology applications, may not be suitable for delineating cardiovascular or neurological hypoxia. For this reason, new Cu hypoxia positron emission tomography (PET) imaging agents are being examined to search for a higher selectivity for hypoxic or ischemic tissue at higher oxygen concentrations found in these tissues. Two approaches are to increase alkylation or to replace the sulfur atoms with selenium, resulting in the formation of selenosemicarbazones.

Methods: Three Cu-64-labeled selenosemicarbazone complexes were synthesized and one was screened for hypoxia selectivity in vitro using EMT-6 mouse mammary carcinoma cells. Rodent biodistribution and small animal PET images were obtained from BALB/c mice implanted with EMT-6 tumors. One alkylated thiosemicarbazone was synthesized and examined.

Results: Of the three bis(selenosemicarbazone) ligands synthesized and examined, only Cu-64-diacetyl-bis(selenosemicarbazone) [(CU)-C-64-ASSM] was isolated in high-enough radiochemical purity to undertake cell uptake experiments where uptake was shown to be independent of oxygen concentration. The bis(thiosemicarbazone) complex synthesized, Cu-64-diacetyl-bis(N-4-ethylthiosemicarbazone) [Cu-64-ATSE], showed hypoxia selectivity similar to Cu-64-ATSM although at a higher oxygen concentration. Biodistribution studies for (CU)-C-64-ASSM and Cu-64-ATSE showed high tumor uptake at 20 min (Cu-64-ASSM, 10.33 +/- 0.78% fD/g; Cu-64-ATSE, 7.71 +/- 0.46% ID/g). PET images of EMT-6 tumor-bearing mice visualized the tumor with Cu-64-ATSE and revealed hypoxia selectivity consistent with the in vitro data.

Conclusion: Of the compounds synthesized, only Cu-64-ASSM and Cu-64-ATSE could be examined in vitro and in vivo. Although the stability of bis(selenosemicarbazone) complexes increased upon addition of methyl groups to the diimine backbone, the fully alkylated species, Cu-64-ASSM, demonstrated no hypoxia selectivity. However, the additional alkylation present in Cu-ATSE modifies the hypoxia selectivity and in vivo properties when compared with Cu-ATSM.

Item Type: Article
DOI/Identification number: 10.1016/j.nucmedbio.2004.10.004
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Divisions > Division of Natural Sciences > Physics and Astronomy
Depositing User: Michael Went
Date Deposited: 30 Aug 2008 20:51 UTC
Last Modified: 16 Nov 2021 09:42 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/3764 (The current URI for this page, for reference purposes)

University of Kent Author Information

Went, Michael J..

Creator's ORCID:
CReDIT Contributor Roles:

Blower, Philip J..

Creator's ORCID:
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.